The role of complement in CD4+ T cell homeostasis and effector functions

Seminars in Immunology

Volumn 25, Issue 1, 2013, Pages 12-19

  Kolev, Martin ^a   Le Friec, Gaëlle ^a   Kemper, Claudia ^a  

^a GUY S HOSPITAL   (United Kingdom)

Author keywords

CD4+ T cell; Complement; Homeostasis; Metabolism; Notch

Indexed keywords

ADENOSINE TRIPHOSPHATE; ALTERNATIVE COMPLEMENT PATHWAY C3 C5 CONVERTASE; CASPASE; COMPLEMENT; COMPLEMENT COMPONENT C3A; COMPLEMENT COMPONENT C3B; COMPLEMENT COMPONENT C5A; COMPLEMENT FACTOR D; COMPLEMENT RECEPTOR; CYCLIC AMP DEPENDENT PROTEIN KINASE; DECAY ACCELERATING FACTOR; GAMMA INTERFERON; INTERLEUKIN 1BETA; INTERLEUKIN 2; INTERLEUKIN 23; INTERLEUKIN 6; INTERLEUKIN 7; INTERLEUKIN 7 RECEPTOR; NEUTROPHIL CYTOPLASMIC ANTIBODY; PHOSPHOTRANSFERASE; PLASMA PROTEIN; PROLINE RICH PROTEIN; PROPERDIN; PROTEIN; PROTEINASE; RIBOSOME PROTEIN; SERINE; THREONINE; TOLL LIKE RECEPTOR 2; UNINDEXED DRUG;

ADAPTIVE IMMUNITY; ALLERGIC ENCEPHALOMYELITIS; AUTOPHAGY; B LYMPHOCYTE; BLOOD CLOTTING; CELL FUNCTION; CELL GROWTH; COMPLEMENT ACTIVATION; COMPLEMENT SYSTEM; CONTROL; DENDRITIC CELL; EFFECTOR CELL; EPITHELIUM CELL; HOMEOSTASIS; HUMAN; HUMORAL IMMUNITY; IMMUNE RESPONSE; IMMUNE SYSTEM; INFECTION; INNATE IMMUNITY; MACROPHAGE; METABOLISM; MONOCYTE; NEUTROPHIL; NONHUMAN; PATHOGENESIS; REGULATORY MECHANISM; REVIEW; STRESS; SYSTEMIC LUPUS ERYTHEMATOSUS; T LYMPHOCYTE; T LYMPHOCYTE ACTIVATION; TH1 CELL;

CD4(+) T CELL; COMPLEMENT; HOMEOSTASIS; METABOLISM; NOTCH;

ANIMALS; ANTIGENS, CD4; CD4-POSITIVE T-LYMPHOCYTES; COMPLEMENT SYSTEM PROTEINS; HOMEOSTASIS; HUMANS; TH1 CELLS; TH2 CELLS;

EID: 84879885078     PISSN: 10445323     EISSN: 10963618     Source Type: Journal    
DOI: 10.1016/j.smim.2013.04.012     Document Type: Review

References (105)

1. Walport M. Complement. First of two parts. The New England Journal of Medicine 2001, 344:1058-1066.
2. Klos A., Tenner A., Johswich K., Ager R., Reis E., Köhl J. The role of the anaphylatoxins in health and disease. Molecular Immunology 2009, 46:2753-2766.
3. Walport M. Complement. Second of two parts. The New England Journal of Medicine 2001, 344:1140-1144.
4. Hartmann K., Henz B., Krüger-Krasagakes S., Köhl J., Burger R., Guhl S., et al. C3a and C5a stimulate chemotaxis of human mast cells. Blood 1997, 89:2863-2870.
5. Heurich M., Martínez-Barricarte R., Francis N.J., Roberts D.L., Rodríguez de Córdoba S., Morgan B.P., et al. Common polymorphisms in C3, factor B, and factor H collaborate to determine systemic complement activity and disease risk. Proceedings of the National Academy of Sciences of the United States of America 2011, 108:8761-8766.
6. Mayilyan K.R. Complement genetics, deficiencies, and disease associations. Protein Cell 2012, 3:487-496.
7. Korb L.C., Ahearn J.M. C1q binds directly and specifically to surface blebs of apoptotic human keratinocytes: complement deficiency and systemic lupus erythematosus revisited. Journal of Immunology 1997, 158:4525-4528.
8. Chen M., Daha M.R., Kallenberg C.G. The complement system in systemic autoimmune disease. Journal of Autoimmunity 2010, 34:J276-J286.
9. Le Friec G., Kemper C. Complement: coming full circle. Archivum Immunologiae et Therapiae Experimentalis 2009, 57:393-407.
10. Kemper C., Atkinson J.P. T-cell regulation: with complements from innate immunity. Nature Reviews. Immunology 2007, 7:9-18.
11. Lay W.H., Nussenzweig V. Receptors for complement of leukocytes. The Journal of Experimental Medicine 1968, 128:991-1009.
12. Papamichail M., Gutierrez C., Embling P., Johnson P., Holborow E.J., Pepys M.B. Complement dependence of localisation of aggregated IgG in germinal centres. Scandinavian Journal of Immunology 1975, 4:343-347.
13. Fischer M.B., Ma M., Goerg S., Zhou X., Xia J., Finco O., et al. Regulation of the B cell response to T-dependent antigens by classical pathway complement. Journal of Immunology 1996, 157:549-556.
14. Dempsey P.W., Allison M.E., Akkaraju S., Goodnow C.C., Fearon D.T. C3d of complement as a molecular adjuvant: bridging innate and acquired immunity. Science 1996, 271:348-350.
15. Carter R.H., Spycher M.O., Ng Y.C., Hoffman R., Fearon D.T. Synergistic interaction between complement receptor type 2 and membrane IgM on B lymphocytes. Journal of Immunology 1988, 141:457-463.
16. Fearon D.T., Carter R.H. The CD19/CR2/TAPA-1 complex of B lymphocytes: linking natural to acquired immunity. Annual Review of Immunology 1995, 13:127-149.
17. Fleming S.D., Shea-Donohue T., Guthridge J.M., Kulik L., Waldschmidt T.J., Gipson M.G., et al. Mice deficient in complement receptors 1 and 2 lack a tissue injury-inducing subset of the natural antibody repertoire. Journal of Immunology 2002, 169:2126-2133.
18. Carroll M. The complement system in regulation of adaptive immunity. Nature Immunology 2004, 5:981-986.
19. Barrington R., Zhang M., Fischer M., Carroll M.C. The role of complement in inflammation and adaptive immunity. Immunological Reviews 2001, 180:5-15.
20. Kopf M., Abel B., Gallimore A., Carroll M., Bachmann M.F. Complement component C3 promotes T-cell priming and lung migration to control acute influenza virus infection. Nature Medicine 2002, 8:373-378.
21. Suresh M., Molina H., Salvato M.S., Mastellos D., Lambris J.D., Sandor M. Complement component 3 is required for optimal expansion of CD8T cells during a systemic viral infection. Journal of Immunology 2003, 170:788-794.
22. Köhl J. The role of complement in danger sensing and transmission. Immunologic Research 2006, 34:157-176.
23. Li K., Fazekasova H., Wang N., Peng Q., Sacks S.H., Lombardi G., et al. Functional modulation of human monocytes derived DCs by anaphylatoxins C3a and C5a. Immunobiology 2012, 217:65-73.
24. Song W.C. Crosstalk between complement and toll-like receptors. Toxicologic Pathology 2012, 40:174-182.
25. Astier A., Trescol-Biémont M.C., Azocar O., Lamouille B., Rabourdin-Combe C. Cutting edge: CD46, a new costimulatory molecule for T cells, that induces p120CBL and LAT phosphorylation. Journal of Immunology 2000, 164:6091-6095.
26. Zaffran Y., Destaing O., Roux A., Ory S., Nheu T., Jurdic P., et al. CD46/CD3 costimulation induces morphological changes of human T cells and activation of Vav, Rac, and extracellular signal-regulated kinase mitogen-activated protein kinase. Journal of Immunology 2001, 167:6780-6785.
27. Purcell D., Deacon N., Andrew S., McKenzie I. Human non-lineage antigen, CD46 (HuLy-m5): purification and partial sequencing demonstrates structural homology with complement-regulating glycoproteins. Immunogenetics 1990, 31:21-28.
28. Liszewski M.K., Atkinson J.P. Membrane cofactor protein (MCP; CD46). Isoforms differ in protection against the classical pathway of complement. Journal of Immunology 1996, 156:4415-4421.
29. Ni Choileain S., Astier A.L. CD46 processing: a means of expression. Immunobiology 2012, 217:169-175.
30. Liszewski M.K., Atkinson J.P. Membrane cofactor protein. Current Topics in Microbiology and Immunology 1992, 178:45-60.
31. Westra D., Volokhina E., van der Heijden E., Vos A., Huigen M., Jansen J., et al. Genetic disorders in complement (regulating) genes in patients with atypical haemolytic uraemic syndrome (aHUS). Nephrology, Dialysis, Transplantation 2010, 25:2195-2202.
32. Le Friec G., Sheppard D., Whiteman P., Karsten C.M., Shamoun S.A., Laing A., et al. The CD46-Jagged1 interaction is critical for human TH1 immunity. Nature Immunology 2012, 13:1213-1221.
33. Liao W., Lin J.X., Leonard W.J. Interleukin-2 at the crossroads of effector responses, tolerance, and immunotherapy. Immunity 2013, 38:13-25.
34. Strainic M.G., Liu J., Huang D., An F., Lalli P.N., Muqim N., et al. Locally produced complement fragments C5a and C3a provide both costimulatory and survival signals to naive CD4+ T cells. Immunity 2008, 28:425-435.
35. Drouin S.M., Corry D.B., Hollman T.J., Kildsgaard J., Wetsel R.A. Absence of the complement anaphylatoxin C3a receptor suppresses Th2 effector functions in a murine model of pulmonary allergy. Journal of Immunology 2002, 169:5926-5933.
36. Lajoie S., Lewkowich I.P., Suzuki Y., Clark J.R., Sproles A.A., Dienger K., et al. Complement-mediated regulation of the IL-17A axis is a central genetic determinant of the severity of experimental allergic asthma. Nature Immunology 2010, 11:928-935.
37. Tsujimura A., Shida K., Kitamura M., Nomura M., Takeda J., Tanaka H., et al. Molecular cloning of a murine homologue of membrane cofactor protein (CD46): preferential expression in testicular germ cells. The Biochemical Journal 1998, 330(Pt 1):163-168.
38. Quigg R.J., Holers V.M. Characterization of rat complement receptors and regulatory proteins. CR2 and Crry are conserved, and the C3b receptor of neutrophils and platelets is distinct from CR1. Journal of Immunology 1995, 155:1481-1488.
39. Quigg R.J., Lo C.F., Alexander J.J., Sneed A.E., Moxley G. Molecular characterization of rat Crry: widespread distribution of two alternative forms of Crry mRNA. Immunogenetics 1995, 42:362-367.
40. Soltys J., Wu X. Complement regulatory protein Crry deficiency contributes to the antigen specific recall response in experimental autoimmune myasthenia gravis. Journal of Inflammation (London) 2012, 9:20.
41. Jiménez-Periañez A., Ojeda G., Criado G., Sánchez A., Pini E., Madrenas J., et al. Complement regulatory protein Crry/p65-mediated signaling in T lymphocytes: role of its cytoplasmic domain and partitioning into lipid rafts. Journal of Leukocyte Biology 2005, 78:1386-1396.
42. Fernández-Centeno E., de Ojeda G., Rojo J.M., Portolés P. Crry/p65, a membrane complement regulatory protein, has costimulatory properties on mouse T cells. Journal of Immunology 2000, 164:4533-4542.
43. + regulatory T cells. Nature Immunology 2013, 14:162-171.
44. Dunkelberger J.R., Song W.C. Role and mechanism of action of complement in regulating T cell immunity. Molecular Immunology 2010, 47:2176-2186.
45. Cardone J., Le Friec G., Vantourout P., Roberts A., Fuchs A., Jackson I., et al. Complement regulator CD46 temporally regulates cytokine production by conventional and unconventional T cells. Nature Immunology 2010, 11:862-871.
46. Crimeen-Irwin B., Ellis S., Christiansen D., Ludford-Menting M.J., Milland J., Lanteri M., et al. Ligand binding determines whether CD46 is internalized by clathrin-coated pits or macropinocytosis. The Journal of Biological Chemistry 2003, 278:46927-46937.
47. Wagner C., Ochmann C., Schoels M., Giese T., Stegmaier S., Richter R., et al. The complement receptor 1, CR1 (CD35), mediates inhibitory signals in human T-lymphocytes. Molecular Immunology 2006, 43:643-651.
48. Longhi M., Harris C., Morgan B., Holding Gallimore A. T cells in check - a new role for complement regulators. Trends in Immunology 2006, 27:102-108.
49. Sivasankar B., Longhi M., Gallagher K., Betts G., Morgan B., Godkin A., et al. CD59 blockade enhances antigen-specific CD4+ T cell responses in humans: a new target for cancer immunotherapy. Journal of Immunology 2009, 182:5203-5207.
50. Laumonnier Y., Schmudde I., Köhl J. The role of complement in the diagnosis and management of allergic rhinitis and allergic asthma. Current Allergy and Asthma Reports 2011, 11:122-130.
51. Hashimoto M., Hirota K., Yoshitomi H., Maeda S., Teradaira S., Akizuki S., et al. Complement drives Th17 cell differentiation and triggers autoimmune arthritis. The Journal of Experimental Medicine 2010, 207:1135-1143.
52. Weaver D.J., Reis E.S., Pandey M.K., Kohl G., Harris N., Gerard C., et al. C5a receptor-deficient dendritic cells promote induction of Treg and Th17 cells. European Journal of Immunology 2010, 40:710-721.
53. Cheng S.C., Sprong T., Joosten L.A., van der Meer J.W., Kullberg B.J., Hube B., et al. Complement plays a central role in Candida albicans-induced cytokine production by human PBMCs. European Journal of Immunology 2012, 42:993-1004.
54. Kwan W.H., van der Touw W., Paz-Artal E., Li M.O., Heeger P.S. Signaling through C5a receptor and C3a receptor diminishes function of murine natural regulatory T cells. The Journal of Experimental Medicine 2013, 210:257-268.
55. Denkers E.Y., Gazzinelli R.T. Regulation and function of T-cell-mediated immunity during Toxoplasma gondii infection. Clinical Microbiology Reviews 1998, 11:569-588.
56. Allen J.E., Wynn T.A. Evolution of Th2 immunity: a rapid repair response to tissue destructive pathogens. PLoS Pathogens 2011, 7:e1002003.
57. Kinugasa T., Sakaguchi T., Gu X., Reinecker H.C. Claudins regulate the intestinal barrier in response to immune mediators. Gastroenterology 2000, 118:1001-1011.
58. Rennick D.M., Fort M.M., Davidson N.J. Studies with IL-10-/- mice: an overview. Journal of Leukocyte Biology 1997, 61:389-396.
59. Morgan B., Gasque P. Extrahepatic complement biosynthesis: where, when and why. Clinical and Experimental Immunology 1997, 107:1-7.
60. Tang S., Zhou W., Sheerin N.S., Vaughan R.W., Sacks S.H. Contribution of renal secreted complement C3 to the circulating pool in humans. Journal of Immunology 1999, 162:4336-4341.
61. Würzner R., Joysey V.C., Lachmann P.J. Complement component C7. Assessment of in vivo synthesis after liver transplantation reveals that hepatocytes do not synthesize the majority of human C7. Journal of Immunology 1994, 152:4624-4629.
62. Truedsson L., Sturfelt G., Offenbartl K., Sjöholm A.G. The spleen is not a major synthetic site of alternative pathway components. Complement and Inflammation 1990, 7:52-56.
63. Tenner A.J., Volkin D.B. Complement subcomponent C1q secreted by cultured human monocytes has subunit structure identical with that of serum C1q. The Biochemical Journal 1986, 233:451-458.
64. Whaley K. Biosynthesis of the complement components and the regulatory proteins of the alternative complement pathway by human peripheral blood monocytes. The Journal of Experimental Medicine 1980, 151:501-516.
65. White R.T., Damm D., Hancock N., Rosen B.S., Lowell B.B., Usher P., et al. Human adipsin is identical to complement factor D and is expressed at high levels in adipose tissue. The Journal of Biological Chemistry 1992, 267:9210-9213.
66. Baumann H., Prowse K.R., Marinković S., Won K.A., Jahreis G.P. Stimulation of hepatic acute phase response by cytokines and glucocorticoids. Annals of the New York Academy of Sciences 1989, 557:280-295. [discussion 95-6].
67. Baumann H., Gauldie J. The acute phase response. Immunology Today 1994, 15:74-80.
68. Katz Y., Stav D., Barr J., Passwell J.H. IL-13 results in differential regulation of the complement proteins C3 and factor B in tumour necrosis factor (TNF)-stimulated fibroblasts. Clinical and Experimental Immunology 1995, 101:150-156.
69. Van Kooten C., Boonstra J.G., Paape M.E., Fossiez F., Banchereau J., Lebecque S., et al. Interleukin-17 activates human renal epithelial cells in vitro and is expressed during renal allograft rejection. Journal of the American Society of Nephrology 1998, 9:1526-1534.
70. Circolo A., Pierce G.F., Katz Y., Strunk R.C. Antiinflammatory effects of polypeptide growth factors, Platelet-derived growth factor, epidermal growth factor, and fibroblast growth factor inhibit the cytokine-induced expression of the alternative complement pathway activator factor B in human fibroblasts. The Journal of Biological Chemistry 1990, 265:5066-5071.
71. Gerritsma J.S., van Kooten C., Gerritsen A.F., van Es L.A., Daha M.R. Transforming growth factor-beta 1 regulates chemokine and complement production by human proximal tubular epithelial cells. Kidney International 1998, 53:609-616.
72. Pratt J.R., Basheer S.A., Sacks S.H. Local synthesis of complement component C3 regulates acute renal transplant rejection. Nature Medicine 2002, 8:582-587.
73. Pavlov V., Raedler H., Yuan S., Leisman S., Kwan W.H., Lalli P.N., et al. Donor deficiency of decay-accelerating factor accelerates murine T cell-mediated cardiac allograft rejection. Journal of Immunology 2008, 181:4580-4589.
74. Heeger P., Lalli P., Lin F., Valujskikh A., Liu J., Muqim N., et al. Decay-accelerating factor modulates induction of T cell immunity. The Journal of Experimental Medicine 2005, 201:1523-1530.
75. Lalli P.N., Strainic M.G., Yang M., Lin F., Medof M.E., Heeger P.S. Locally produced C5a binds to T cell-expressed C5aR to enhance effector T-cell expansion by limiting antigen-induced apoptosis. Blood 2008, 112:1759-1766.
76. Blom A., Villoutreix B., Dahlbäck B. Complement inhibitor C4b-binding protein-friend or foe in the innate immune system. Molecular Immunology 2004, 40:1333-1346.
77. Liszewski M.K., Kolev M., Bertram P.M., Yamammoto H., Leung M., Atkinson J.P., et al. Cleavage of intracellular C3 into C3a and C3b by cathepsin L is required for human T cell induction. Immunobiology 2012, p1146.
78. Davoust N., Nataf S., Reiman R., Holers M.V., Campbell I.L., Barnum S.R. Central nervous system-targeted expression of the complement inhibitor sCrry prevents experimental allergic encephalomyelitis. Journal of Immunology 1999, 163:6551-6556.
79. Liu J., Miwa T., Hilliard B., Chen Y., Lambris J., Wells A., et al. The complement inhibitory protein DAF (CD55) suppresses T cell immunity in vivo. The Journal of Experimental Medicine 2005, 201:567-577.
80. Passwell J., Schreiner G.F., Nonaka M., Beuscher H.U., Colten H.R. Local extrahepatic expression of complement genes C3, factor B, C2, and C4 is increased in murine lupus nephritis. The Journal of Clinical Investigation 1988, 82:1676-1684.
81. Mizuno M., Nishikawa K., Goodfellow R.M., Piddlesden S.J., Morgan B.P., Matsuo S. The effects of functional suppression of a membrane-bound complement regulatory protein, CD59, in the synovial tissue in rats. Arthritis and Rheumatism 1997, 40:527-533.
82. Mizuno M., Nishikawa K., Morgan B.P., Matsuo S. Comparison of the suppressive effects of soluble CR1 and C5a receptor antagonist in acute arthritis induced in rats by blocking of CD59. Clinical and Experimental Immunology 2000, 119:368-375.
83. Mizuno M., Nishikawa K., Spiller O.B., Morgan B.P., Okada N., Okada H., et al. Membrane complement regulators protect against the development of type II collagen-induced arthritis in rats. Arthritis and Rheumatism 2001, 44:2425-2434.
84. Lin M., Yin N., Murphy B., Medof M.E., Segerer S., Heeger P.S., et al. Immune cell-derived c3 is required for autoimmune diabetes induced by multiple low doses of streptozotocin. Diabetes 2010, 59:2247-2252.
85. Sancak Y., Bar-Peled L., Zoncu R., Markhard A.L., Nada S., Sabatini D.M. Ragulator-Rag complex targets mTORC1 to the lysosomal surface and is necessary for its activation by amino acids. Cell 2010, 141:290-303.
86. Kim E., Goraksha-Hicks P., Li L., Neufeld T.P., Guan K.L. Regulation of TORC1 by Rag GTPases in nutrient response. Nature Cell Biology 2008, 10:935-945.
87. Le Friec G., Köhl J., Kemper C. A complement a day keeps the Fox(p3) away. Nature Immunology 2013, 14:110-112.
88. Yu L., McPhee C.K., Zheng L., Mardones G.A., Rong Y., Peng J., et al. Termination of autophagy and reformation of lysosomes regulated by mTOR. Nature 2010, 465:942-946.
89. Joubert P.E., Meiffren G., Grégoire I.P., Pontini G., Richetta C., Flacher M., et al. Autophagy induction by the pathogen receptor CD46. Cell Host and Microbe 2009, 6:354-366.
90. De Palma C., Morisi F., Cheli S., Pambianco S., Cappello V., Vezzoli M., et al. Autophagy as a new therapeutic target in Duchenne muscular dystrophy. Cell Death and Disease 2012, 3:e418.
91. Zoncu R., Efeyan A., Sabatini D.M. mTOR: from growth signal integration to cancer, diabetes and ageing. Nature Reviews. Molecular Cell Biology 2011, 12:21-35.
92. Vilà L., Roglans N., Baena M., Barroso E., Alegret M., Merlos M., et al. Metabolic alterations and increased liver mTOR expression precede the development of autoimmune disease in a murine model of lupus erythematosus. PLoS ONE 2012, 7:e51118.
93. Ricklin D., Hajishengallis G., Yang K., Lambris J.D. Complement: a key system for immune surveillance and homeostasis. Nature Immunology 2010, 11:785-797.
94. Markiewski M.M., DeAngelis R.A., Benencia F., Ricklin-Lichtsteiner S.K., Koutoulaki A., Gerard C., et al. Modulation of the antitumor immune response by complement. Nature Immunology 2008, 9:1225-1235.
95. Delgoffe G.M., Pollizzi K.N., Waickman A.T., Heikamp E., Meyers D.J., Horton M.R., et al. The kinase mTOR regulates the differentiation of helper T cells through the selective activation of signaling by mTORC1 and mTORC2. Nature Immunology 2011, 12:295-303.
96. Liao W., Lin J.X., Leonard W.J. IL-2 family cytokines: new insights into the complex roles of IL-2 as a broad regulator of T helper cell differentiation. Current Opinion in Immunology 2011, 23:598-604.
97. Shalapour S., Deiser K., Kühl A.A., Glauben R., Krug S.M., Fischer A., et al. Interleukin-7 links T lymphocyte and intestinal epithelial cell homeostasis. PLoS ONE 2012, 7:e31939.
98. Penaranda C., Kuswanto W., Hofmann J., Kenefeck R., Narendran P., Walker L.S., et al. IL-7 receptor blockade reverses autoimmune diabetes by promoting inhibition of effector/memory T cells. Proceedings of the National Academy of Sciences of the United States of America 2012, 109:12668-12673.
99. Hafler D.A., Compston A., Sawcer S., Lander E.S., Daly M.J., De Jager P.L., et al. Risk alleles for multiple sclerosis identified by a genomewide study. The New England Journal of Medicine 2007, 357:851-862.
100. Ni Choileain S., Astier A.L. CD46 plasticity and its inflammatory bias in multiple sclerosis. Archivum Immunologiae et Therapiae Experimentalis 2011, 59:49-59.
101. Astier A.L., Meiffren G., Freeman S., Hafler D.A. Alterations in CD46-mediated Tr1 regulatory T cells in patients with multiple sclerosis. The Journal of Clinical Investigation 2006, 116:3252-3257.
102. Amsen D., Antov A., Flavell R.A. The different faces of Notch in T-helper-cell differentiation. Nature Reviews. Immunology 2009, 9:116-124.
103. Michalek R.D., Rathmell J.C. The metabolic life and times of a T-cell. Immunological Reviews 2010, 236:190-202.
104. Verbist K.C., Wang R., Green D.R. T cell metabolism and the immune response. Seminars in Immunology 2012, 24:399-404.
105. Heikamp E.B., Powell J.D. Sensing the immune microenvironment to coordinate T cell metabolism, differentiation & function. Seminars in Immunology 2012, 24:414-420.